| |
| |
|
| Insider
Information: |
Mitchener Stephen |
| Relationship: |
SVP, Chief Business Of... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
128,313 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$138,578 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
128,313 |
|
|
| Total
Value |
$138,578 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
SVP, Chief Business Of... |
2023-03-01 |
128,313 |
2021-05-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KPTI |
Karyopharm Therapeutics I... |
SVP, Chief Business Officer |
• – – |
2023-03-01 |
4 |
S |
$3.03 |
$19,257 |
D/D |
(6,357) |
128,313 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, Chief Business Officer |
• – – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
134,670 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, Chief Business Officer |
• – – |
2022-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
70,546 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, Chief Business Officer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
47,250 |
50,546 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, Chief Business Officer |
• – – |
2021-12-02 |
4 |
S |
$6.69 |
$3,338 |
D/D |
(499) |
3,296 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, Chief Business Officer |
• – – |
2021-06-02 |
4 |
S |
$9.29 |
$4,905 |
D/D |
(528) |
2,472 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, Chief Business Officer |
• – – |
2021-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
3,000 |
0 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
